Aquatic Capital Management LLC Akero Therapeutics, Inc. Transaction History

Aquatic Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.76 - $31.18 $351,648 - $617,364	19,800 New	19,800 $500,000
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $1,015 - $3,404	100 Added 11.11%	1,000 $34,000
Q2 2022 Aug 15, 2022	BUY	$8.0 - $15.01 $2,400 - $4,503	300 Added 50.0%	900 $9,000
Q1 2022 May 16, 2022	BUY	$12.97 - $22.26 $7,782 - $13,356	600 New	600 $9,000

168

72.7M

178K

164K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.31B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.